Critical issues in response evaluation on computed tomography: Lessons from the gastrointestinal stromal tumor model

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Reporting results of cancer treatment

1981 • 7,916 citations

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

1998 • 4,380 citations

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

2002 • 4,254 citations

PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

2003 • 2,224 citations

Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

2001 • 1,849 citations

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

1999 • 1,653 citations

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

2004 • 1,629 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

2000 • 1,264 citations

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

2000 • 1,038 citations

Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors

2003 • 665 citations

Management of malignant gastrointestinal stromal tumours

2002 • 574 citations

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)

2003 • 528 citations

CT Evaluation of the Response of Gastrointestinal Stromal Tumors After Imatinib Mesylate Treatment: A Quantitative Analysis Correlated with FDG PET Findings

2004 • 453 citations

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target

2003 • 399 citations

A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

2004 • 338 citations

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

2004 • 324 citations

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.

2004 • 310 citations

ARG tyrosine kinase activity is inhibited by STI571

2001 • 264 citations

Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)

2002 • 261 citations

The RECIST criteria: implications for diagnostic radiologists

2001 • 259 citations

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

2002 • 231 citations

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate

2004 • 210 citations

NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.

2004 • 171 citations

Oncological applications of FDG PET imaging.

1999 • 155 citations

Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology

2000 • 151 citations

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation

2004 • 93 citations

Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec

2003 • 73 citations

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology

2001 • 49 citations

F-18 FDG PET Imaging in Gastrointestinal Stromal Tumor

2003 • 32 citations

Clonal evolution of resistance to imatinib (IM) in patients (pts) with gastrointestinal stromal tumor (GIST): molecular and radiologic evaluation of new lesions

2004 • 19 citations

Principles and technology of PET scanning

2000 • 13 citations

International criteria for measurement of tumour response.

2001 • 12 citations